MOLLY LUTZ: Open Payments
NPI 1821588476 · ERLANGER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,864 in 114 payments from 14 companies in 2025. Trend: 2023 $21,380 · 2024 $10,727 · 2025 $10,864
Speaker / faculty: $9,000Food & beverage: $1,857Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $9,572 |
| Teva Pharmaceuticals USA, Inc. | 8 | $229 |
| Neurocrine BioSciences, Inc. | 14 | $172 |
| Axsome Therapeutics, Inc. | 11 | $171 |
| Otsuka America Pharmaceutical, Inc. | 13 | $161 |
| Supernus Pharmaceuticals, Inc. | 13 | $138 |
| Lundbeck LLC | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $92 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
Products named: VRAYLAR, AUSTEDO XR, INGREZZA, REXULTI, Auvelity, Qelbree, ABILIFY MAINTENA, CAPLYTA.
Industry payments across KY — which companies pay providers there.
